Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Frier

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|January 5, 2008
Diabetes, cognitive impairment, and dementiaMark W J Strachan, Jacqueline F Price, Brian M Frier
Diabetes Care|January 28, 2003
Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetesAndrew J Sommerfield, Ian J Deary, Vincent McAulay, et al.
Diabetes, Obesity & Metabolism|October 20, 2023
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trialWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|November 3, 2025
Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetesWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2024
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc AnalysisWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Thyroid : Official Journal of the American Thyroid Association|December 14, 2004
Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screeningRoderick E Warren, Petros Perros, Moffat J Nyirenda, et al.
Neuropsychology|February 25, 2003
Moderate hypoglycemia impairs multiple memory functions in healthy adultsAndrew J Sommerfield, Ian J Deary, Vincent McAulay, et al.
Journal of Medical Economics|December 17, 2009
Costs of managing severe hypoglycaemia in three European countriesMette Hammer, Morten Lammert, Susana Monereo Mejías, et al.
Diabetes, Obesity & Metabolism|December 11, 2019
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagonVivian T Thieu, Beth D Mitchell, Oralee J Varnado, et al.
BMJ Open Diabetes Research & Care|August 17, 2021
100 years on: the impact of the discovery of insulin on clinical outcomesJohn B Buse, Melanie J Davies, Brian M Frier, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|January 5, 2008
Diabetes, cognitive impairment, and dementiaMark W J Strachan, Jacqueline F Price, Brian M Frier
Diabetes Care|January 28, 2003
Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetesAndrew J Sommerfield, Ian J Deary, Vincent McAulay, et al.
Diabetes, Obesity & Metabolism|October 20, 2023
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trialWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|November 3, 2025
Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetesWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2024
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc AnalysisWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Thyroid : Official Journal of the American Thyroid Association|December 14, 2004
Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screeningRoderick E Warren, Petros Perros, Moffat J Nyirenda, et al.
Neuropsychology|February 25, 2003
Moderate hypoglycemia impairs multiple memory functions in healthy adultsAndrew J Sommerfield, Ian J Deary, Vincent McAulay, et al.
Journal of Medical Economics|December 17, 2009
Costs of managing severe hypoglycaemia in three European countriesMette Hammer, Morten Lammert, Susana Monereo Mejías, et al.
Diabetes, Obesity & Metabolism|December 11, 2019
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagonVivian T Thieu, Beth D Mitchell, Oralee J Varnado, et al.
BMJ Open Diabetes Research & Care|August 17, 2021
100 years on: the impact of the discovery of insulin on clinical outcomesJohn B Buse, Melanie J Davies, Brian M Frier, et al.
Pageof 12